InterviewGTGioneering Genomics for Health and Wellness
⚕️FY23 revenue up 28% YoY to $8.7 million (AUD)geneType Multi-Risk test now implemented in 64 clinicsPeer-reviewed publication confirms geneType risk test outperforms traditional risk assessments for breast cancer by up to 9xTargeting 10k general practitioners across AustraliaMaterial progress for commercial rollout in US with Alva10 & large payer engagementNew US business manager gaining traction with concierge medicine groups & independent doctor networks.⚕️
⚕️Now everything will be fine!⚕️
- Forums
- ASX - By Stock
- Pioneering Genomics for Health and Wellness
GTG
genetic technologies limited
Add to My Watchlist
0.00%
!
3.9¢

InterviewGTG:Pioneering Genomics for Health and Wellness⚕️FY23...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
GTG (ASX) Chart |
Day chart unavailable